Concepedia

Author

Ulrike Heider

Charité - Universitätsmedizin Berlin

Also Known As

Heider U., Heider, Ulrike, U Heider, U. HEIDER, U. Heider, Ulrike Heider

106

Publications

3.9K

Citations

37

H-Index

71

Concepts

All Affiliations

Charité - Universitätsmedizin BerlinHumboldt-Universität zu BerlinUniversity of GöttingenZero to ThreeNovartis (United States)
UH

About

Ulrike Heider is an author at Charité - Universitätsmedizin Berlin specializing in medicine, immunology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

24

27

1.6K

2

Health Sciences

6

6

244

3

Natural Sciences

1

1

50

4

Public Health

1

1

107

5

Biochemistry

1

1

102

Ulrike Heider

×

45

Publications

2.8K

Citations

32

H-Index

YearCitations

Bortezomib inhibits human osteoclastogenesis

Ivana von Metzler, Holger Krebbel, Monica Hecht,

Leukemia

2007

205

Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma

Ulrike Heider, Jessica Rademacher, Britta Lamottke,

European Journal Of Haematology

2009

172

Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment

Ulrike Heider, Martin Kaiser, Christian Müller,

European Journal Of Haematology

2006

170

Serum concentrations of DKK‐1 correlate with the extent of bone disease in patients with multiple myeloma

Martin Kaiser, Maren Mieth, Peter Liebisch,

European Journal Of Haematology

2008

157

Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.

Ulrike Heider, Corinna Langelotz, Christian Jakob,

PubMed

2003

157

Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma

Christian Jakob, Karl Egerer, Peter Liebisch,

Blood

2006

125

Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function

Ivana Zavrski, Holger Krebbel, Britt Wildemann,

Biochemical and Biophysical Research Communications

2005

114

Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries

Ulrike Heider, I. Pedal, Katharina Spanel-Borowski

Fertility and Sterility

2001

107

Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19

Ramona Timm, R. Kaiser, Jörn Lötsch,

The Pharmacogenomics Journal

2005

102

Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma

Ulrike Heider, Ivana von Metzler, Martin Kaiser,

European Journal Of Haematology

2007

96

Page 1